|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09606 DUALITYBIO-B
Nominal 
283.200 -15.200 (-5.094%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 285,781 | 816,335 |
| Net Cash from / (used in) Investing Activities | -- | (211,151) | (78,550) |
| Net Cash from / (used in) Financing Activities | -- | (7,621) | 10,817 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 67,009 | 748,602 |
| Cash & Cash Equivalents at beginning of period | -- | 1,130,889 | 375,974 |
| Effect of Foreign Exchange Rate Changes | -- | 11,008 | 6,313 |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,208,906 | 1,130,889 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -2,073,865 |
| %Change | 606.747% |
| EPS / (LPS) | RMB -49.700 |
| NBV Per Share (¥) | RMB 33.086 |